StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.20−0.15 (-42.59%)

Close on Nov 13, 2026Market cap $906.90KP/E –Yield –

Oragenics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2014 it was 60.7%, against 66.7% the year before. The highest annual figure on record is 66.7% in fiscal 2013.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2014Dec 31, 201460.7%−6.1
FY2013Dec 31, 201366.7%+32.7
FY2012Dec 31, 201234.0%−16.6
FY2011Dec 31, 201150.6%+20.3
FY2010Dec 31, 201030.3%–

More Oragenics figures

See a number that looks wrong?